Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Optimizing AAV Outcomes: Maintenance Therapies
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Andreas Kronbichler, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Managing Patients With AAV in the Rheumatology Clinic
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Christina Economides, MD
Brian Howard, MD
David N. Kenigsberg, MD, FACC
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Jessica Griffiths, PA-C
Anna L. Rourke, NP
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Hongya Chen, PharmD
Jennifer Day, PharmD
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Beyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
Dmitry M. Yaranov, MD
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
Naomi Fisher, MD
Florian Rader, MD
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Biff F. Palmer, MD
The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCPE
Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE
Patrick J. McCann, MD